|
Open label safety study (OLSS) of tipranavir/ritonavir in HIV patients with limited treatment options Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on Open label safety study (OLSS) of tipranavir/ritonavir in HIV patients with limited treatment options conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Open label safety study (OLSS) of tipranavir/ritonavir in HIV patients with limited treatment options Clinical research trials and Open label safety study (OLSS) of tipranavir/ritonavir in HIV patients with limited treatment options healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including Open label safety study (OLSS) of tipranavir/ritonavir in HIV patients with limited treatment options. Open label safety study (OLSS) of tipranavir/ritonavir in HIV patients with limited treatment options Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Open label safety study (OLSS) of tipranavir/ritonavir in HIV patients with limited treatment options clinical trial. Test subjects oftentimes recieve the best healthcare possible for their Open label safety study (OLSS) of tipranavir/ritonavir in HIV patients with limited treatment options condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "O" Clinical Trials Conditions > Open label safety study (OLSS) of tipranavir/ritonavir in HIV patients with limited treatment options  Open label safety study (OLSS) of tipranavir/ritonavir in HIV patients with limited treatment options
Open label safety study (OLSS) of tipranavir/ritonavir in HIV patients with limited treatment options
For Condition: HIV Infections
Status: Recruiting
Sponsor(s): Boehringer Ingelheim Pharmaceuticals ,
Synopsis: Provide early access to tipranavir and evaluate the safety/tolerability of tipranavir in patients with progressive, systemic HIV-1 disease who have failed or are intolerant to currently approved HIV treatments and are ineligible or unable to participate in other tipranavir trials.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 13 Years/
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: 1. Laboratory diagnosis of HIV infection 2. Age =/> 13 years; between ages of 13 and 18 years, must weigh at least 110 lbs (50 kg); no weight restriction if over 18 years of age CD4+ cell count than 10,000 copies/mL 3. Tipranavir required to construct a viable combination of ARV agents for therapy 4. Written informed consent form from patient and/or legal guardian (for patients under 18 years of age) 5. Negative pregnancy test result for female patient of childbearing potential 6. Patient uses an effective barrier method of contraception and as protection against transmitting the virus to a sexual partner(s) 7. Patient is willing to follow protocol requirements EXCLUSION CRITERIA: 1. Patient living within 100 miles of a Phase III site and who is eligible for participating in tipranavir/ritonavir Phase III or companion clinical studies 2. Hypersensitivity to the active ingredients or any of the excipients to tipranavir or ritonavir 3. Patient with the following baseline laboratory findings: - AST/ALT >5X ULN OR total bilirubin >3.5X ULN - AST/ALT >2.5X ULN AND total bilirubin >2X ULN 4. Intended use of additional protease inhibitors in combination with tipranavir/ritonavir 5. Required use of restricted medications 6. Clinical conditions (e.g., substance abuse, mental illness, other medical illness) or prior therapies, which in the investigator’s opinion would preclude the patient from participating 7. Pregnant or breast feeding female patient
Total Enrollment:
Location and Contact Information:
Kaiser Permanente Medical Center *Recruiting*
San Francisco, California, 94118
United States
Recruiting
Henry Ford Hospital, IDD *Recruiting*
Detroit, Michigan, 48202
United States
Recruiting
Olmos Park Medical Associates *Recruiting*
San Antonio, Texas, 78212
United States
Recruiting
34th Street Community Health Center *Not yet recruiting*
Bakersfield, California, 93301
United States
Not yet recruiting
Presbyterian Hospital University Penn *Recruiting*
Philadelphia, Pennsylvania, 19104
United States
Recruiting
Community Research Initiative *Not yet recruiting*
Boston, Massachusetts, 02215
United States
Not yet recruiting
Polari Medical Group *Recruiting*
New York City, New York, 10011
United States
Recruiting
Wayne State University Health Center *Not yet recruiting*
Detroit, Michigan, 48201
United States
Not yet recruiting
Burnside Clinic *Recruiting*
Columbia, South Carolina, 29206
United States
Recruiting
Hillsborough County Health Dept. *Recruiting*
Tampa, Florida, 33602
United States
Recruiting
University of Cincinnati Medical Center *Recruiting*
Cincinnati, Ohio, 45267-0405
United States
Recruiting
Kaiser Permanente - IDC *Not yet recruiting*
Portland, Oregon, 97227
United States
Not yet recruiting
Dupont Circle Physicians Group *Not yet recruiting*
Washington D.C., District of Columbia, 20009
United States
Not yet recruiting
University of TX Medical Center at Dallas *Recruiting*
Dallas, Texas, 75390-9113
United States
Recruiting
AIDS Health Care Foundation *Recruiting*
Los Angeles, California, 90015
United States
Recruiting
IDC Research Initiative *Not yet recruiting*
Altamonte Springs, Florida, 32701
United States
Not yet recruiting
Brigham Women's Hospital DID *Recruiting*
Boston, Massachusetts, 02115
United States
Recruiting
Tarrant County Infectious Diseases Association *Not yet recruiting*
Ft. Worth, Texas, 76104
United States
Not yet recruiting
Ocean View Internal Medicine *Recruiting*
Garden Grove, California, 92845
United States
Recruiting
Whitman Walker Clinic *Recruiting*
Washington D.C., District of Columbia, 20009
United States
Recruiting
HIV Outpatient Program *Recruiting*
New Orleans, Louisiana, 70112
United States
Recruiting
University of CA at LA *Recruiting*
Los Angeles, California, 90024-9694
United States
Recruiting
Richmond AIDS Consortium *Recruiting*
Richmond, Virginia, 23219
United States
Recruiting
Comprehensive Research Institute *Not yet recruiting*
Tampa, Florida, 33607
United States
Not yet recruiting
Southwest CARE Ctr. *Recruiting*
Santa Fe, New Mexico, 87505
United States
Recruiting
Saint Michael's Medical Center *Not yet recruiting*
Newark, New Jersey, 07102
United States
Not yet recruiting
Atlanta Medical Center *Recruiting*
Atlanta, Georgia, 30309
United States
Recruiting
University of NC, Chapel Hill *Recruiting*
Chapel Hill, North Carolina, 27599
United States
Recruiting
Comprehensive Care Center *Recruiting*
Nashville, Tennessee, 37203
United States
Recruiting
Northwestern University *Not yet recruiting*
Chicago, Illinois, 60611
United States
Not yet recruiting
John Hopkins Hospital *Not yet recruiting*
Baltimore, Maryland, 21287
United States
Not yet recruiting
The Schrader Clinic *Not yet recruiting*
Houston, Texas, 77098
United States
Not yet recruiting
AIDS Community Research Initiative of America (ACRIA) *Recruiting*
New York City, New York, 10018
United States
Recruiting
Washington University School of Medicine *Recruiting*
St. Louis, Missouri, 63110
United States
Recruiting
Local Institution *Recruiting*
New York City, New York, 10016
United States
Recruiting
University of Wisconsin Hospital *Recruiting*
Madison, Wisconsin, 53792
United States
Recruiting
Case Western Reserve University *Not yet recruiting*
Cleveland, Ohio, 44106
United States
Not yet recruiting
University of California USC Medical Center *Recruiting*
Los Angeles, California, 90033-1079
United States
Recruiting
The Core Center *Not yet recruiting*
Chicago, Illinois, 60612
United States
Not yet recruiting
Local Institution *Recruiting*
Miami, Florida, 33139
United States
Recruiting
Providence Medical Center *Recruiting*
Portland, Oregon, 97213
United States
Recruiting
Kansas City Free Health Clinic *Recruiting*
Kansas City, Missouri, 64111
United States
Recruiting
Kaiser Los Angeles *Recruiting*
Los Angeles, California, 90027
United States
Recruiting
Mayo Medical Clinic *Not yet recruiting*
Rochester, Minnesota, 55905
United States
Not yet recruiting
Local Institution *Recruiting*
Honolulu, Hawaii, 96816
United States
Recruiting
Local Institution *Not yet recruiting*
Brooklyn, New York, 11206
United States
Not yet recruiting
Health Service Center *Not yet recruiting*
Hobson City, Alabama, 36201
United States
Not yet recruiting
Spectrum Medical *Recruiting*
Scottsdale, Arizona, 85253
United States
Recruiting
Medical University of South Carolina *Not yet recruiting*
Charleston, South Carolina, 29425
United States
Not yet recruiting
LAGLC, Lambda Medical Group *Recruiting*
Los Angeles, California, 90028
United States
Recruiting
Local Institution *Recruiting*
San Francisco, California, 94114
United States
Recruiting
Local Institution *Recruiting*
Miami, Florida, 33143
United States
Recruiting
Consultants for Infectious Diseases *Not yet recruiting*
Lincoln, Nebraska, 68506
United States
Not yet recruiting
Local Institution *Not yet recruiting*
New York City, New York, 10014
United States
Not yet recruiting
Synergy Hematology/Oncology *Recruiting*
Los Angeles, California, 90036
United States
Recruiting
Swedish Medical Ctr. *Recruiting*
Seattle, Washington, 98104
United States
Recruiting
East Bay AIDS Center *Recruiting*
San Francisco, California, 94705
United States
Recruiting
Circle Medical, LLC *Recruiting*
Norwalk, Connecticut, 06851
United States
Recruiting
Hennepin County Medical Center *Not yet recruiting*
Minneapolis, Minnesota, 55415
United States
Not yet recruiting
University of Pittsburgh *Recruiting*
Pittsburgh, Pennsylvania, 15213
United States
Recruiting
Local Institution *Not yet recruiting*
Philadelphia, Pennsylvania, 19107
United States
Not yet recruiting
Local Institution *Recruiting*
Houston, Texas, 77004
United States
Recruiting
Wellness Center *Recruiting*
Las Vegas, Nevada, 89102
United States
Recruiting
The center for HIV Prevention and Care *Not yet recruiting*
Santa Rosa, California, 95404
United States
Not yet recruiting
Kaiser Permanente - Franklin Medical Center *Not yet recruiting*
Denver, Colorado, 80205
United States
Not yet recruiting
Additional Information:
Study ID Numbers: BI 1182.58;
Study Start Date: May 2003
Record last reviewed: May 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00062660
Other Hiv Infections Studies:
1. A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants
2. A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines
3. ALVAC-HIV vCP1452 Alone and Combined with MN rgp120
4. A Study of Viracept in AIDS Patients with Cytomegalovirus Retinitis
5. Phase II trial of an anti-HIV-1 gene transfer product
Related Studies:
Other HIV Infections Clinical Trials
Other Hawaii Clinical Trials
Other Honolulu Clinical Trials
Open label safety study (OLSS) of tipranavir/ritonavir in HIV patients with limited treatment options
|
|
|
|
|
|
|
|
